Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Morc2 S87L mutation in mice mimics human Charcot-Marie-Tooth disease

May 30, 2022

NLRP3 inflammasome inhibitor INF-176 for the treatment of Alzheimer's disease

May 30, 2022

New myasthenia gravis rat model developed

May 27, 2022

VeriSIM Life partners with Total Brain to support neurological drug development

May 27, 2022

IMT-504 ameliorates neuropathic pain by modulating neuroimmune milieu

May 27, 2022

Aging mice brains have slower protein turnover, linking aging to neurodegenerative disease

May 27, 2022

Athira Pharma discloses new HGFR modulators

May 27, 2022

U.S. researchers present new NR1D2 agonists

May 26, 2022

Antigen-specific immunotolerance platform shows preclinical proof of concept for Parkinson's disease

May 24, 2022

Entrada's EEV treatments progress for Duchenne muscular dystrophy, myotonic dystrophy type 1

May 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...